Aldehyde reductase gene expression by lipid peroxidation end products, MDA and HNE.
Membrane lipid peroxidation results in the production of a variety of aldehydic compounds that play a significant role in aging, drug toxicity and the pathogenesis of a number of human diseases, such as atherosclerosis and cancer. Increased lipid peroxidation and reduced antioxidant status may also contribute to the development of diabetic complications. This study reports that lipid peroxidation end products such as malondialdehyde (MDA) and 4-hydroxynonenal (HNE) induce aldehyde reductase (ALR) gene expression. MDA and HNE induce an increase in intracellular peroxide levels; N-Acetyl-L-cysteine (NAC) suppressed MDA- and HNE-induced ALR gene expression. These results indicate that increased levels of intracellular peroxides by MDA and HNE might be involved in the upregulation of ALR.
Department of Biochemistry, Osaka University Medical School, Suita, Japan.
Y H
YH
Koh
Y S
YS
Park
M
M
Takahashi
K
K
Suzuki
N
N
Taniguchi
D000111:Acetylcysteine / Q000494:pharmacology; D000449:Aldehyde Reductase / Q000096:biosynthesis* / Q000235:genetics*; D000447:Aldehydes / Q000494:pharmacology*; D000818:Animals; D001011:Aorta; D002118:Calcium / Q000494:pharmacology; D002478:Cells, Cultured; D004790:Enzyme Induction / Q000187:drug effects; D015870:Gene Expression / Q000187:drug effects*; D015227:Lipid Peroxidation; D008315:Malondialdehyde / Q000494:pharmacology*; D009131:Muscle, Smooth, Vascular / Q000201:enzymology; D010766:Phosphorylation; D019000:Phosphotyrosine / Q000378:metabolism; D051381:Rats; D017208:Rats, Wistar
D000447:Aldehydes; D019000:Phosphotyrosine; D008315:Malondialdehyde; D000449:Aldehyde Reductase; C027576:4-hydroxy-2-nonenal; D002118:Calcium; D000111:Acetylcysteine